ML Caramori, M Mauer - Current opinion in nephrology and hypertension, 2003 - journals.lww.com Recent findings: There have been advances in the understanding of diabetic
nephropathy pathology. Clearly, structural changes may be advanced before any
clinical findings are apparent. Not all functional consequences of the ... Cited by 68 - Related articles - BL Direct - All 7 versions
E Zintzaras, I Stefanidis - Journal of human genetics, 2005 - Springer Abstract The association between diabetic nephropathy (DN) and the XbaI
polymorphism in the GLUT1 gene has been investigated in several case-control
studies. These studies rendered contradictory results: the allele XbaI(À) ... Cited by 39 - Related articles - All 6 versions
- ►shouxi.net KG Ewens, RA George, K Sharma, FN … - Diabetes, 2005 - Am Diabetes Assoc Several lines of evidence, including familial aggregation, suggest that allelic
variation contributes to risk of diabetic nephropathy. To assess the evidence
for specific susceptibility genes, we used the transmission/disequilibrium ... Cited by 34 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org K Susztak, K Sharma, M Schiffer, P McCue, E … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Clinical studies have identified risk factors that correlate with the
development of ESRD in diabetes. The presence of microalbuminuria, hypertension,
and poor glycemic control are the most important risk factors (3). It is ... Cited by 25 - Related articles - BL Direct - All 6 versions
DPK Ng, AS Krolewski - Current Molecular Medicine, 2005 - ingentaconnect.com 1 Department of Community, Occupational and Family Medicine, and Centre for
Molecular Epidemiology, National University of Singapore 2 Joslin Diabetes
Center, and Department of Medicine, Harvard Medical School, Boston, MA, USA ... Cited by 22 - Related articles - BL Direct - All 3 versions
FC Brosius, CW Heilig - Pediatric Nephrology, 2005 - Springer Abstract Changes in glucose transporter expression in glomerular cells occur
early in diabetes. These changes, especially the GLUT1 increase in mesangial
cells, appear to play a pathogenic role in the development of ECM expansion ... Cited by 14 - Related articles - All 3 versions
DPK Ng, D Koh, S Choo, KS Chia - Clinica Chimica Acta, 2006 - Elsevier Saliva is a potentially useful but untapped source of genomic DNA for genetic
epidemiological studies. However, current commercial methods are mainly
concerned with DNA extraction and do not address important issues ... Cited by 13 - Related articles - All 3 versions
H Rincon-Choles, F Thameem, DM Lehman, R … - American journal of therapeutics, 2005 - journals.lww.com Diabetes mellitus is the leading cause of end-stage renal disease. Development
and progression of diabetic nephropathy result from a combination of genetic
susceptibility and metabolic and hemodynamic abnormalities. In America, ... Cited by 11 - Related articles - BL Direct - All 5 versions
- Free from Publisher CE Mogensen - Diabetes care, 2003 - Am Diabetes Assoc Diabetic renal disease is still an extremely important and common complication
in both type 1 and type 2 diabetic patients. Every clinician and nephrologist
knows that diabetic patients constitute a large proportion of clientele in ... Cited by 12 - Related articles - BL Direct - All 5 versions
T Page, AD Hodgkinson, M Ollerenshaw, … - Cancer genetics and cytogenetics, 2005 - Elsevier Clear-cell renal cell carcinoma (CCRCC) is identified by abundant glycogen-rich
cytoplasm, due to the aberrant influx and storage of glucose. The objective was
to investigate the frequency of polymorphisms of the facilitative glucose ... Cited by 10 - Related articles - All 11 versions
